Other Relevant Information
Other relevant Information
GRIFOLS, S.A. guarantees that the texts published in this page correspond exactly and entirely with the texts sent to the CNMV by the Company or by third parties. All the communications are available in the Web page of the CNMV.
Grifols reports the closing of private placement of Senior Secured Notes and Revolving Credit Facility extension
December 11, 2024
Grifols' Board of Directors unanimously appoints Pascal Ravery and Paul S. Herendeen as new members of the Board
December 9, 2024
Thomas Glanzmann becomes non-executive Chairman
September 23, 2024
Grifols provides explanations on credit rating agencies updates and the news published in media
June 27, 2024
Grifols completes sale of a 20% equity stake in Shanghai RAAS and forges strategic alliance with Haier Group
June 18, 2024
Information on the resolutions approved at the General Shareholders' Meeting of June 14, 2024
June 14, 2024
Grifols reports the closing of the private placement of additional EUR 300 million senior secured notes
June 04, 2024
Grifols changes the category of Board Members Raimon Grifols Roura and Víctor Grifols Deu
May 31, 2024
Grifols announces several agreements approved by the Board of Directors to strength it’s corporate governance system
May 07, 2024
Grifols successfully completes its EUR 1 billion private placement of senior secured notes
April 30, 2024
Grifols announces signing of private offering of EUR 1 billion senior secured notes due 2030
April 23, 2024
Clarification to the CNMV requirements 04.04.24
April 4, 2024
Grifols provides responses to CNMV March 21 report
April 4, 2024
Nacho Abia begins tenure as new Grifols CEO
April 2, 2024
Grifols continues to execute its deleveraging path
March 14, 2024
Grifols reports its 2023 Consolidated Annual Accounts
March 8, 2024
Grifols additional information
March 1, 2024
Grifols provides further information on the Free Cash Flow expected for 2024 and onwards
March 1, 2024
Grifols announces the completion of the confirmatory due diligence by Haier on SRAAS transaction
March 1, 2024
Grifols appoints new Board member
February 27, 2024
Grifols comments on the false insinuations published by a short-seller
February 20, 2024
Grifols changes its corporate governance structure
February 5, 2024
Grifols filed a lawsuit against Daniel Yu, Gotham City Research LLC, General Industrial Partners LLP, Cyrus de Weck, and their affiliates.
January 26, 2024
Grifols invites investors to listen to conference call on January 11
January 10, 2024
Information as a continuation of the communications filed yesterday by the Company as a consequence of the Gotham City Research report
January 10, 2024
Grifols comments on the false information published by Gotham
January 9, 2024
2023
Changes to the composition of Grifols Board of Directors
December 19, 2023
Amendment of the Internal Regulations of the Board of Directors
December 19, 2023
The Board of Directors approves the clawback policy
October 20, 2023
Information on the resolutions approved at the General Meeting of Shareholders on June 16, 2023
June 16, 2023
Grifols approves a long term incentive plan based
May 10, 2023
Reorganization of the Audit Committee
April 18, 2023
Amendment of the Internal Regulations of the Board of Directors
February 24, 2023
2022
Grifols' statement on articles published in certain Spanish media
October 21, 2022
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
October 3, 2022
Board of Directors communication in the context of considerable geopolitical uncertainty and market volatility
September 26, 2022
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada
September 7, 2022
Grifols sold MedKeeper to affiliates of the US company Becton Dickinson for US$ 93 million
July 28, 2022
Information on the resolutions approved at the General Meeting of Shareholders on June 10, 2022
June 10, 2022
Grifols completes the acquisition of Biotest
April 25, 2022
2021
Grifols and GIC obtain authorization for their strategic agreement for USD 1 billion
November 17, 2021
Grifols initiate the launch of a €2bn equivalent senior unsecured notes
September 27, 2021
Consent solicitation results on Secured and Unsecured Notes to amend certain provisions of the senior debt
August 6, 2021
Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan
July 30, 2021
Termination of the buyback programme
June 14, 2021
Information on the resolutions approved at the General Meeting of Shareholders on May 21, 2021
May 21, 2021
Recurring information under the buy-back programme of shares
April 26, 2021
Recurring information under the buy-back programme of shares
April 19, 2021
Notice of Annual General Shareholders' Meeting 2021
April 16, 2021
Recurring information under the buy-back programme of shares
April 12, 2021
Grifols advances in the execution of its expansion plan with the acquisition of 7 plasma centers in the U.S.
April 7, 2021
Recurring information under the buy-back programme of shares
March 29, 2021
Recurring information under the buy-back programme of shares
March 22, 2021
Buy-back plan of shares
March 12, 2021
Grifols reinforces its innovation strategy after completing the acquisition of GigaGen
March 9, 2021
Grifols acquires 25 U.S.-based plasma centers from BPL ensuring one million additional liters for fractionation
March 1, 2021
The Regulations of the Sustainability Committee
February 22, 2021
2020
Grifols amends certain articles of the Regulations of the Board of Directors and creates a Sustainability Committee
December 16, 2020
Grifols closes the acquisition of Alkahest
December 15, 2020
Grifols strategically expands its operations into Egypt
November 24, 2020
Grifols acquires the remaining 49% of MedKeeper
November 9, 2020
Information on the resolutions approved at the General Meeting of Shareholders on October 9, 2020
October 9, 2020
Grifols closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S.
October 1, 2020
Grifols continues strengthening its innovation strategy with the acquisition of Alkahest
September 7, 2020
Notice of Annual General Shareholders' Meeting 2020
September 4, 2020